Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Futura Medical PLC (GB:FUM)
LSE:FUM
Holding GB:FUM?
Track your performance easily
FUM Stock Chart & Stats
Day’s Range0p - 0p
52-Week Range23.28p - 50.00p
Previous Close36.4p
Volume402.57K
Average Volume (3M)398.46K
Market Cap
£110.06M
Enterprise Value106.03M
Total Cash (Recent Filing)£4.03M
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta0.54
Next Earnings
Apr 09, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.01
Shares Outstanding301,449,541
10 Day Avg. Volume732,250
30 Day Avg. Volume398,463
Standard Deviation0.39
R-Squared0.05
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)1216.67
Price to Sales (P/S)64.59
Price to Cash Flow (P/CF)-93.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
140.00pPrice Target Upside284.62% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Futura Medical News
PremiumCompany Announcements
Futura Medical Executives Adjust Shareholdings
PremiumCompany Announcements
Futura Medical Projects Rising Revenues with Eroxon®
PremiumCompany Announcements
Futura Medical’s Profit Surge on Eroxon® SuccessPremiumCompany Announcements
Futura Medical’s Eroxon Hits US Market
PremiumCompany Announcements
Futura Medical’s Eroxon® Hits U.S. Market
PremiumCompany Announcements
Futura Medical Set to Unveil Mid-Year Financials
PremiumCompany Announcements
Futura Medical’s Eroxon Set for U.S. DebutPremiumCompany Announcements
Futura Medical Announces Share Capital and Product SuccessOptions Prices
Currently, No data available
---
Ownership Overview
1.43% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
98.57% Public Companies and
Individual Investors
FUM FAQ
What was Futura Medical PLC’s price range in the past 12 months?
Futura Medical PLC lowest share price was 23.28p and its highest was 50.00p in the past 12 months.
What is Futura Medical PLC’s market cap?
Currently, no data Available
When is Futura Medical PLC’s upcoming earnings report date?
Futura Medical PLC’s upcoming earnings report date is Apr 09, 2025 which is in 201 days.
How were Futura Medical PLC’s earnings last quarter?
Futura Medical PLC released its earnings results on Sep 10, 2024. The company reported 0.003p earnings per share for the quarter, beating the consensus estimate of N/A by 0.003p.
Is Futura Medical PLC overvalued?
According to Wall Street analysts Futura Medical PLC’s price is currently Undervalued.
Does Futura Medical PLC pay dividends?
Futura Medical PLC does not currently pay dividends.
What is Futura Medical PLC’s EPS estimate?
Futura Medical PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Futura Medical PLC have?
Futura Medical PLC has 302,363,650 shares outstanding.
What happened to Futura Medical PLC’s price movement after its last earnings report?
Futura Medical PLC reported an EPS of 0.003p in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -5%.
Which hedge fund is a major shareholder of Futura Medical PLC?
Currently, no hedge funds are holding shares in GB:FUM
---
Futura Medical Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
140.00p (284.62% Upside)
140.00p (284.62% Upside)
Insider Transactions
Sold Shares
Worth £183.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-27.20%
12-Months-Change
Fundamentals
Return on Equity
-47.40%
Trailing 12-Months
Asset Growth
-7.26%
Trailing 12-Months
Company Description
Futura Medical PLC
Futura Medical PLC is a drug manufacturer based in the United Kingdom. It lays primary focus exclusively on topically applied pharmaceutical drugs and medical devices which are developed using a highly efficient and proprietary transdermal delivery technology, DermaSys. DermaSys is a versatile technology that can be customized to suit the specific active compound being used and the therapeutic indication. Futura's products are used mainly for the treatment of erectile dysfunction and pain relief.
---
FUM Stock 12 Month Forecast
Average Price Target
140.00p
▲(284.62% Upside)
Technical Analysis
Open Orphan Plc
―
EKF Diagnostics Holdings
―
PureTech Health
―
Hikma Pharmaceuticals
―
Best Analysts Covering FUM
1 Year
1 Year Success Rate
2/4 ratings generated profit
1 Year Average Return
-1.00%
reiterated a buy rating 10 days ago
Copying James Orsborne's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of -1.00% per trade.
---